Mupirocina Farmalider (Mupirocin)

Mupirocin is used topically to treat bacterial skin infections by targeting susceptible organisms.

• Impetigo: reduces bacterial load and promotes healing of superficial lesions.
• Secondary bacterial skin infections: controls infection and limits spread.
• Folliculitis: eliminates the causative bacteria and relieves inflammation.
• Erysipelas: treats the acute bacterial skin inflammation and prevents complications.

• Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, an enzyme essential for attaching isoleucine to its tRNA during protein synthesis. By blocking this step, the drug prevents formation of functional bacterial proteins, producing a bacteriostatic effect against Gram‑positive organisms such as Staphylococcus aureus and Streptococcus pyogenes, while having minimal impact on human cells.

Topical application of mupirocin may cause local and, rarely, systemic adverse reactions.

Common Side Effects

• Burning sensation at the application site
• Itching or mild erythema
• Dryness or peeling of the skin

Serious or Rare Side Effects

• Allergic contact dermatitis
• Stevens‑Johnson syndrome or toxic epidermal necrolysis
• Anaphylaxis or severe systemic hypersensitivity

Before using Mupirocina Farmalider, consider the following precautions to ensure safe and effective therapy.

• Assess for allergy: verify patient has no known hypersensitivity to mupirocin or other topical antibiotics.
• Limit duration: avoid prolonged use beyond the prescribed period to reduce resistance risk.
• Avoid occlusion: do not cover the treated area with airtight dressings unless directed.
• Use on intact skin: apply only to superficial lesions; avoid large broken skin areas.
• Monitor pediatric use: exercise caution in infants and young children, adjusting application as advised.
• Store at room temperature: keep in the original container, protect from moisture and heat.

Mupirocin may interact with other topical or systemic agents; consider the following.

Major Interactions (Avoid)

• Concurrent use with other topical antibiotics (e.g., bacitracin, neomycin): may increase local irritation and resistance.
• Application over areas treated with corticosteroids: can mask signs of infection and alter healing.

Moderate Interactions (Monitor Closely)

• Systemic antibiotics: may reduce the need for mupirocin or alter bacterial flora.
• Immunosuppressive therapy: patients may have higher risk of infection, requiring close monitoring.
• Antifungal creams: combined use may cause skin irritation.